Project Grant HT94252410514
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,163,218.00 to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) to conduct research on SLC37A3 as a novel prostate cancer target. The award period runs from July 15, 2024 to July 14, 2028. Through this funding, Case Western Reserve University will carry out...
The U.S. Department of Defense (DoD) awarded a $497,747 project grant to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a novel, central nervous system-penetrant synthetic oleanane triterpenoid for the treatment of diffuse intrinsic pontine glioma (DIPG), a rare and aggressive form of pediatric brain...
This $872,237 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project on "Pulmonary Rehabilitation in Advanced Lung Cancer Survivors" led by Case Western Reserve University (CWRU). The 3-year project, commencing on May 1, 2025 and concluding on April 30, 2028, aims to investigate innovative approaches to address the medical needs of military personnel and veterans affected by advanced...
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...
This federal Project Grant award, valued at $9,870,517.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a pilot randomized controlled trial of the ISENS system for sensorimotor restoration after limb loss, to be conducted by Case Western Reserve University (CWRU) in Cleveland, Ohio. The key products and services to be delivered under this 4-year award, from July 1, 2025 to June 30, 2029, include advanced...
The Case Western Reserve University will receive $1,168,656 in funding from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to support the project "FADD: A MECHANISTIC BASIS AND THERAPEUTIC OPPORTUNITY FOR OVERCOMING CDK4/6 INHIBITOR RESISTANCE" from April 1, 2023 to March 31, 2026. Through this three-year Project Grant, Case Western Reserve University researchers will investigate mechanisms of resistance to...
This $630,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports The Ohio State University's research to develop a targeted antibody and immunotoxin combination therapy to improve treatment of T-cell lymphoma. The award period is from July 15, 2023 to July 14, 2025. This research aims to transform health care for Service Members and the American public through innovative and impactful medical solutions for the...
Case Western Reserve University will receive $2,469,361 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to support the SANGUISTOP project. This four-year Project Grant will fund research into intravenous nanomedicine for targeted thrombin delivery in hemorrhage control. The Military Medical Research and Development program aims to transform military and public health care through innovative medical solutions for...
This federal Project Grant award of $3,908,980.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant funding will support research by Case Western Reserve University (CWRU) to enhance walking and independence for individuals with incomplete spinal cord injuries through the development of a fully implanted neuroprosthesis. The 4-year project, running from September 2024 to September 2028, aims to advance biomedical...
The federal Project Grant award in the amount of $2,271,024.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand next-generation immunotherapy responses in metastatic uveal melanoma. The award, effective November 1, 2024 through October 31, 2028, is provided to the University of Colorado-Denver, a prominent public research university. The university has a strong track record of federal contract and...